A comparison of the AUC difference of ROC curves for CA-62 and CEA confirmed that the CA-62 marker is the most accurate in identifying early stages of NSCLC in asymptomatic patients. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.